The effect of traumatic brain injury on learning and memory: A synaptic focus. The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry , 31 (2), 195–214. https ...

A new study suggests that damage to a key part of the brain involved in judgment and emotional regulation could explain why ...

The FDA has fast-tracked a drug to treat severe traumatic brain injury from Swedish pharma NeuroVive, hastening its development and review. Based in Lund, NeuroVive is developing NeuroSTAT for ...

What you need to know A 73 year old man is brought to the emergency department following a ground level fall a few hours earlier. His physiological observations are normal, but he cannot remember any ...

A former Bandidos bikie involved in the infamous Broadbeach Brawl has walked from court over a “heinous” and vicious attack ...

In a 2018 study of children diagnosed with a traumatic brain injury from mild to severe, the American Academy of Pediatrics (AAP) found 39% developed neuropsychiatric symptoms up to 5 years after ...

Detailed price information for Helius Medical Technologies Inc (HSDT-Q) from The Globe and Mail including charting and trades.

PoNS Therapeutic Experience Program (PoNSTEP) study demonstrates durable long-term beneficial effects of PoNS Therapy® on gait deficit improvement in people with Multiple Sclerosis- -Presentation of ...

- CignaHealth becomes fifth major payer to authorize claim for PoNS Device at out-of-network adjusted negotiated list price of $19,161--This follows another recent authorization by Anthem ...

- CignaHealth becomes fifth major payer to authorize claim for PoNS Device at out-of-network adjusted negotiated list price of $19,161- -This follows another recent authorization by Anthem Multiplan ...

NEWTOWN, Pa., June 16, 2025 (GLOBE NEWSWIRE) — Helius Medical Technologies, Inc. (Nasdaq: HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic ...

Aetna approves reimbursement for the PoNS Device, joining Anthem and United, enhancing access for MS patients.